Hologic, Inc. et al v. SenoRx, Inc
Filing
519
AMENDED STIPULATION AND ORDER 517 Extending Case Schedule Deadlines. Signed by Judge Ronald M. Whyte on 8/8/12. (jg, COURT STAFF) (Filed on 8/8/2012)
1
2
3
4
Nicholas H. Lee (SBN 229588)
ARNOLD & PORTER LLP
777 S. Figueroa Street, 44th Floor
Los Angeles, CA 90017-5844
Telephone: (213) 243-4000
Facsimile: (213) 243-4199
E-mail: nicholas.lee@aporter.com
Jeffrey E. Faucette (SBN 193066)
SKAGGS FAUCETTE LLP
One Embarcadero Center, Suite 500
San Francisco, CA 94111
Telephone: (415) 315-1669
Facsimile: (415) 433-5994
E-mail: jeff@skaggsfaucette.com
Matthew M. Wolf (admitted pro hac vice)
John E. Nilsson (admitted pro hac vice)
ARNOLD & PORTER LLP
555 Twelfth Street N.W.
Washington, DC 20004-1206
Telephone: (202) 942-5000
Facsimile: (202) 942-5999
E-mail: matthew.wolf@aporter.com
E-mail: john.nilsson@aporter.com
Bruce R. Genderson (admitted pro hac vice)
Aaron P. Maurer (admitted pro hac vice)
Adam D. Harber (admitted pro hac vice)
WILLIAMS & CONNOLLY LLP
725 Twelfth Street, NW
Washington, DC 20005
Telephone: (202) 434-5000
Facsimile: (202) 434-5029
E-mail: bgenderson@wc.com
E-mail: amaurer@wc.com
E-mail: aharber@wc.com
5
6
7
8
9
10
11
12
Attorneys for Plaintiffs
HOLOGIC, INC., CYTYC CORP.
and HOLOGIC L.P.
Attorneys for Defendant
SENORX, INC.
13
14
IN THE UNITED STATES DISTRICT COURT
15
NORTHERN DISTRICT OF CALIFORNIA
16
SAN JOSE DIVISION
17
18
HOLOGIC, INC., CYTYC CORP. and
HOLOGIC L.P.,
19
20
21
22
Plaintiffs,
Case No.: C-08-0133 RMW
AMENDED JOINT STIPULATION AND
[PROPOSED] ORDER EXTENDING
CASE SCHEDULE DEADLINES
vs.
SENORX, INC.,
Defendant.
23
24
25
26
27
28
AMENDED J OINT STIPULATION AND [PROPOSED] ORDER EXTENDING CASE SCHEDULE DEADLINES
CASE NO. C-08-0133 RMW
1
Plaintiffs and Defendant hereby submit this Amended Joint Stipulation and [Proposed]
2
Order requesting an extension of the deadlines in the current Scheduling Order, entered by this
3
Court on March 6, 2012. The parties stipulate and agree to move all deadlines as detailed below.
4
The parties agree that no prejudice will come to this matter by this extension. The parties, through
5
their counsel, hereby lodge the following proposed updated case management statement.
6
I.
SCOPE OF ISSUES FOR RETRIAL AND DISCOVERY
7
The only issues remaining for trial are those of invalidity and willfulness. Based upon the
8
January 3, 2012 Case Management Conference, the parties agree to limited discovery as set forth
9
below, and the following updated schedule for such discovery and for the other deadlines in this
10
case.
11
II.
PROPOSED SCHEDULE
12
A.
Fact Discovery
13
On or before February 28, 2012, Hologic shall identify to SenoRx via letter all objective
14
indicia of non-obviousness on which it intends to rely, with a brief description of the facts on which
15
Hologic will rely to support each alleged indicator. All fact discovery shall be commenced in time
16
to be completed by September 14, 2012. Document production shall be limited to:
17
an updated production of public statements and communications to third-parties
18
concerning the commercial performance, features, clinical performance and/or
19
benefits of any commercial embodiment of an invention(s) of claims 1 and/or 8 of
20
the ‘142 patent. Documents falling within this category would include quarterly and
21
annual reports, press releases, transcripts of investor calls, advertisements, marketing
22
presentations, brochures, sell sheets, and correspondence with customers;
23
alleged to fall within claims 1 and/or 8 of the ‘142 patent;
24
25
annual sales revenue figures for any commercial embodiment of an invention(s)
to the extent that Hologic intends to rely on the Hologic Mammosite® Multi-Lumen
26
product as an embodiment of claims 1 and/or 8 of the ‘142 patent, Hologic shall
27
produce documents concerning the reason(s) a Multi-Lumen product was introduced,
28
the perceived need (or lack thereof) for such a device, the reason(s) the Multi-Lumen
-2AMENDED J OINT STIPULATION AND [PROPOSED] ORDER EXTENDING CASE SCHEDULE DEADLINES
CASE NO. C-08-0133 RMW
1
product was not introduced earlier, comparisons versus the Single Lumen
2
MammoSite® product, the date of the first proposal for the Multi-Lumen product,
3
the instructions for use for the Multi-Lumen product, and the actual use of the Multi-
4
Lumen product, including any evidence of conformance.
5
Any such production shall be completed by August 14, 2012. In addition, each side may
6
serve one deposition notice pursuant to Rule 30(b)(6) of the Federal Rules of Civil Procedure
7
concerning documents produced pursuant to this order and/or any other discovery provided
8
pursuant to this order. Any such deposition(s) are to be completed on or before September 14,
9
2012. Each party may also update its Rule 26(a) Disclosures pursuant to its obligations under the
10
Federal Rules.
11
B.
Expert Discovery
12
All expert discovery shall be commenced in time to be completed by November 20, 2012.
13
Expert discovery shall be limited to the issue of objective evidence of non-obviousness. In this
14
regard, Plaintiff may submit an expert report on the issue of objective evidence of non-obviousness
15
on or before September 18, 2012. Defendant may submit a responsive report on or before October
16
19, 2012. Plaintiff may submit a reply report on or before November 2, 2012. And depositions of
17
experts on the issue of objective evidence of non-obviousness are to be completed on or before
18
November 20, 2012.
19
C.
Dispositive Motions
20
Dispositive motions shall be filed no later than December 14, 2012. Responsive briefs shall
21
be filed within 35 days after service of opening briefs. Reply briefs shall be filed within 25 days
22
after service of responsive briefs. Sur-replies shall not be permitted.
23
D.
24
A pre-trial conference shall be set for Thursday, March 14, 2013. Trial shall be set for April
25
Pre-trial and Trial
22, 2013.
26
27
28
-3AMENDED J OINT STIPULATION AND [PROPOSED] ORDER EXTENDING CASE SCHEDULE DEADLINES
CASE NO. C-08-0133 RMW
Respectfully submitted,
1
2
Dated: July 31, 2012
ARNOLD & PORTER LLP
3
s/ Matthew M. Wolf
4
Matthew M. Wolf
5
7
Attorneys for Plaintiffs
HOLOGIC, INC., CYTYC CORP.
and HOLOGIC L.P.
8
WILLIAMS & CONNOLLY LLP
9
s/ Bruce R. Genderson
6
10
Bruce R. Genderson
11
Attorneys for Defendant SENORX, INC.
12
13
ATTESTATION UNDER GENERAL ORDER 45 § X.B
14
15
As required by General Order § X.B, I hereby attest that concurrence in the filing of this
document was obtained from all signatories to this Amended Joint Case Management Statement.
16
17
/s/ Matthew M. Wolf
18
Matthew M. Wolf
Matthew.Wolf@Aporter.com
19
20
ORDER
21
22
23
24
The Court, having considered the parties’ Stipulation Re Case Schedule, hereby grants that
proposed schedule.
IT IS SO ORDERED
Dated:
, 2012
______________________________
Honorable Ronald M. Whyte
United States District Judge
25
26
27
28
-4AMENDED J OINT STIPULATION AND [PROPOSED] ORDER EXTENDING CASE SCHEDULE DEADLINES
CASE NO. C-08-0133 RMW
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?